From Development to Commercialization: Stability Studies for Injectable Biologics
Global requirements, strategies, and best practices throughout the entire product lifecycle
Stability studies are a cornerstone of biopharmaceutical development, playing a critical role in ensuring product quality, patient safety, and regulatory approval. In this webcast, we will provide small and mid-sized biotech companies with a practical overview of stability studies, key regulatory expectations, and effective strategies for designing stability programs across the entire product lifecycle.
We will explore the importance of stability data throughout different stages of development—from early formulation development and clinical trials to commercial manufacturing—and discuss how to address global regulatory requirements as well as the specific challenges associated with different modalities, including oligonucleotides, peptides, mRNA, and other advanced therapeutics.
Watch this on-demand version of our webcast to gain a holistic understanding of the and the key factors influencing product stability for building efficient, compliant, and future-ready stability programs that support successful product development and commercialization.
The on-demand version will be available after November 12.